Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow cbdMD, Inc.

Get SEC filing alerts via email and in your feed for cbdMD, Inc.

YCBD YCBD-PA

cbdMD, Inc.

About cbdMD, Inc.

cbdMD, Inc. develops and distributes hemp-derived dietary supplements, including CBD products, topicals, and functional mushroom blends. Its brands, cbdMD, Paw CBD, and ATRx Labs, serve consumers and pet markets through e-commerce, retail, and international channels. The company emphasizes product quality, scientific research, and brand reputation to differentiate in a competitive, regulatory-sensitive industry focused on health, wellness, and functional ingredients.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from cbdMD, Inc.

1
1
cbdMD, Inc. cbdMD Reports 19% Revenue Growth to $5.64 Million in Q2 Fiscal 2026

Via official filing (AI summary) | 21 days ago | 0 comments

2
1
cbdMD, Inc. cbdMD Reports $5.02 Million in Q1 Fiscal 2026 Sales, Net Loss Improves

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
cbdMD, Inc. cbdMD Reports $2.04 Million Net Loss, Sees Shift in Sales Strategy and New Product Launch

Via official filing (AI summary) | 6 months ago | 0 comments

4
1
cbdMD, Inc. cbdMD Reports 12% Revenue Decline in Q3 Fiscal 2025 Amid Operational Challenges

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
cbdMD, Inc. cbdMD Reports 9% Revenue Growth to $4.75 Million in Q2 Fiscal 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
cbdMD, Inc. cbdMD Reports Q1 Fiscal 2025 Results with $5.1M in Sales and Net Income Turnaround

Via official filing (AI summary) | over 1 year ago | 0 comments